Placental growth factor-1 and epithelial haemato–retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy

[1]  E. Agrón,et al.  Serum inflammatory markers in diabetic retinopathy. , 2005, Investigative ophthalmology & visual science.

[2]  Manju Patel,et al.  A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. , 2005, Ophthalmology.

[3]  Lee M Ellis,et al.  Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells , 2005, Oncogene.

[4]  H. Ozdemir,et al.  Serous macular detachment in diabetic cystoid macular oedema. , 2005, Acta ophthalmologica Scandinavica.

[5]  E. Scott,et al.  SDF-1 is both necessary and sufficient to promote proliferative retinopathy. , 2005, The Journal of clinical investigation.

[6]  M. Shibuya,et al.  A Novel Snake Venom Vascular Endothelial Growth Factor (VEGF) Predominantly Induces Vascular Permeability through Preferential Signaling via VEGF Receptor-1* , 2004, Journal of Biological Chemistry.

[7]  M. Grant,et al.  The role of growth factors in the pathogenesis of diabetic retinopathy , 2004, Expert opinion on investigational drugs.

[8]  N. Mitsiades,et al.  Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. , 2004, The American journal of pathology.

[9]  V. Peponis,et al.  Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. , 2004, Ophthalmology.

[10]  A. D. de Vos,et al.  The Crystal Structure of Placental Growth Factor in Complex with Domain 2 of Vascular Endothelial Growth Factor Receptor-1* , 2004, Journal of Biological Chemistry.

[11]  M. Bartoli,et al.  Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives , 2003, Diabetes/metabolism research and reviews.

[12]  A. Luttun,et al.  VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis , 2003, Cell and Tissue Research.

[13]  A. Howlett,et al.  A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular Permeability , 2003, Journal of Pharmacology and Experimental Therapeutics.

[14]  A. Luttun,et al.  Placental growth factor and its receptor, vascular endothelial growth factor receptor‐1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders , 2003, Journal of thrombosis and haemostasis : JTH.

[15]  J. Rakic,et al.  Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[16]  B. Fu,et al.  Structural mechanisms of acute VEGF effect on microvessel permeability. , 2003, American journal of physiology. Heart and circulatory physiology.

[17]  I. Morita,et al.  Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. , 2003, Biochemical and biophysical research communications.

[18]  M. Shibuya,et al.  VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice. , 2003, Biochemical and biophysical research communications.

[19]  G. Vrensen,et al.  Vascular endothelial growth factors and angiogenesis in eye disease , 2003, Progress in Retinal and Eye Research.

[20]  D. Mottet,et al.  CoCl2, a Chemical Inducer of Hypoxia‐Inducible Factor‐1, and Hypoxia Reduce Apoptotic Cell Death in Hepatoma Cell Line HepG2 , 2002, Annals of the New York Academy of Sciences.

[21]  G. Amerongen,et al.  Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. , 2002 .

[22]  T. Bensaoula,et al.  Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[23]  P. Campochiaro,et al.  Retinal and choroidal neovascularization , 2000, Journal of cellular physiology.

[24]  G. Vrensen,et al.  VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations , 2000 .

[25]  T. Gardner,et al.  Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1 , 1999, The Journal of Biological Chemistry.

[26]  S. Kishi,et al.  Patterns of diabetic macular edema with optical coherence tomography. , 1999, American journal of ophthalmology.

[27]  J. Tarbell,et al.  Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. , 1998, Diabetes.

[28]  N. Ferrara,et al.  Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes , 1997, The Journal of Biological Chemistry.

[29]  R. Masood,et al.  Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Hjelmeland,et al.  ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. , 1996, Experimental eye research.

[31]  Susan Lightman,et al.  Diabetic retinopathy. , 2003, Clinical cornerstone.

[32]  G. Vrensen,et al.  VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A. , 2000, Current eye research.

[33]  M. Boulton,et al.  Increased expression of placenta growth factor in proliferative diabetic retinopathy. , 1998, Laboratory investigation; a journal of technical methods and pathology.